A New Target of Dental Pulp-Derived Stem Cell-Based Therapy on Recipient Bone Marrow Niche in Systemic Lupus Erythematosus
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Recent advances in mesenchymal stem/stromal cell (MSC) research have led us to consider the feasibility of MSC-based therapy for various diseases. Human dental pulp-derived MSCs (hDPSCs) have been identified in the dental pulp tissue of deciduous and permanent teeth, and they exhibit properties with self-renewal and in vitro multipotency. Interestingly, hDPSCs exhibit superior immunosuppressive functions toward immune cells, especially T lymphocytes, both in vitro and in vivo. Recently, hDPSCs have been shown to have potent immunomodulatory functions in treating systemic lupus erythematosus (SLE) in the SLE MRL/ mouse model. However, the mechanisms underlying the immunosuppressive efficacy of hDPSCs remain unknown. This review aims to introduce a new target of hDPSC-based therapy on the recipient niche function in SLE.
Rostami M, Farahani P, Esmaelian S, Bahman Z, Hussein A, A Alrikabi H Stem Cell Rev Rep. 2024; 20(8):2062-2103.
PMID: 39150646 DOI: 10.1007/s12015-024-10770-y.
Carvalho S, Santos J, Moreira L, Duarte A, Gaspar P, Rocha H Int J Mol Sci. 2024; 25(6).
PMID: 38542525 PMC: 10970756. DOI: 10.3390/ijms25063546.
Min Q, Yang L, Tian H, Tang L, Xiao Z, Shen J Int J Mol Sci. 2023; 24(9).
PMID: 37175774 PMC: 10178746. DOI: 10.3390/ijms24098068.
Sonoda S, Yamaza T Front Endocrinol (Lausanne). 2023; 14:1151429.
PMID: 37033255 PMC: 10073676. DOI: 10.3389/fendo.2023.1151429.
Liu B, Li J, Chen B, Shuai Y, He X, Liu K Ann Transl Med. 2023; 11(2):90.
PMID: 36819570 PMC: 9929758. DOI: 10.21037/atm-22-6390.